Guardant Health, Inc. cash flow statement

In fiscal 2025, Guardant Health, Inc.'s operations generated −$185m of cash; it spent $48.3m on capital projects, leaving free cash flow of −$233m. It returned $45.0m through buybacks.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Guardant Health, Inc.: cash flow statement, annual
Fiscal year	2016Dec 2016	2017Dec 2017	2018Dec 2018	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025	LTMJun 2026
Cash from operations	−37	−72	−72	−47	−104	−209	−309	−325	−240	−185	−185
Depreciation and amortisation	4	5	7	11	16	22	36	43	42	40	38
Stock-based pay	2	4	7	17	144	151	95	91	140	166	191
Capital spending	2	7	20	19	36	75	77	20	35	48	56
Free cash flow	−38	−79	−92	−66	−140	−284	−387	−345	−275	−233	−241
Free cash flow after stock pay	−40	−83	−99	−83	−284	−436	−482	−436	−415	−399	−432
Share buybacks	0	7	0	0	0	—	—	0	0	45	0
Shares issued	—	0	254	350	356	0	0	493	0	257	—

US$ millions unless shown otherwise. Fiscal quarters.

Guardant Health, Inc.: cash flow statement, quarterly
Quarter	2024 Q3Sept 2024	2024 Q4Dec 2024	2025 Q1Mar 2025	2025 Q2Jun 2025	2025 Q3Sept 2025	2025 Q4Dec 2025	2026 Q1Mar 2026	2026 Q2Jun 2026
Cash from operations	−51	−65	−63	−60	−35	−26	−66	−58
Depreciation and amortisation	10	10	10	10	9	10	9	9
Stock-based pay	50	36	38	42	43	43	48	58
Capital spending	4	19	4	6	10	28	6	12
Free cash flow	−55	−83	−67	−66	−46	−54	−71	−70
Free cash flow after stock pay	−105	−120	−105	−108	−89	−97	−119	−127
Shares issued	0	0	—	—	—	—	—	—

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: GH vs PNTG GH vs PGNY GH vs HQY GH vs INNV

More: Health Care Services stocks compared, Health Care sector, rankings of US companies

Figures from Guardant Health, Inc.'s SEC filings (10-K and 10-Q), retrieved October 20, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Guardant Health, Inc.